Secondaries announced 4.4.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Viking Therapeutics, Inc. Symbol: VKTX Price: Last trade $1.46 Trade Date: 4/6 Shares: 6.2 million Underwriter(s) Maxim Group, FBR Rating=Subscription Needed[…]